- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
PSME1 Antibody recognizes Proteasome Activator Subunit 1 (PSME1), also known as PA28 alpha or REGalpha, an essential component of the 11S proteasome activator complex. PSME1 associates with the ends of the 20S proteasome core to promote protein degradation independently of ubiquitin, increasing the generation of peptides for presentation by Major Histocompatibility Complex class I molecules. As a key regulator of immunoproteasome activity, PSME1 contributes to antigen processing, immune surveillance, and cellular responses to inflammatory stimuli. Consequently, PSME1 Antibody is widely used to investigate proteasome biology, antigen presentation, immunology, infection, and cancer.
PSME1 is broadly expressed but is strongly induced by interferon gamma and other pro-inflammatory cytokines. Together with PSME2 (PA28 beta), it forms the heteroheptameric PA28 activator complex, which enhances proteasomal cleavage of intracellular proteins into peptides that are efficiently presented to cytotoxic T lymphocytes. Beyond adaptive immunity, PSME1 participates in protein quality control, degradation of oxidatively damaged proteins, regulation of cellular stress responses, and maintenance of proteostasis. Because of these diverse functions, PSME1 plays an important role in preserving cellular homeostasis during inflammation and oxidative stress.
Altered PSME1 expression has been associated with viral infection, autoimmune disease, chronic inflammation, neurodegenerative disorders, and numerous cancers, including melanoma, colorectal cancer, breast cancer, lung cancer, and hepatocellular carcinoma. Increased immunoproteasome activity influences immune cell activation, tumor immune recognition, and responses to immunotherapy, making PSME1 an increasingly important biomarker and therapeutic target. Ongoing studies continue to define its contributions to antigen presentation, immune escape, and inflammatory signaling pathways.
NSJ Bioreagents offers highly validated PSME1 Antibody products for reliable detection of endogenous PSME1 in human and animal tissues. These antibodies support investigations into immunoproteasome activation, antigen processing, immune regulation, proteostasis, and cancer biology while providing dependable performance across western blotting, immunohistochemistry, immunofluorescence, flow cytometry, and other research applications.
Learn more about proteins involved in antigen processing, immune regulation and immunoproteasome function on our Immunology Antibodies page.
Optimal dilution of the PSME1 Antibody / Immunoproteasome Activator Antibody should be determined by the researcher.
E. coli-derived recombinant human protein (amino acids M1-Y249) was used as the immunogen for the PSME1 antibody.
After reconstitution, the PSME1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
PA28 alpha antibody, Proteasome Activator Subunit 1 antibody, REGalpha antibody, PSME1 antibody, Proteasome Activator Alpha antibody, 11S Regulator Alpha antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.